✦ LIBER ✦

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

✍ Scribed by Treat, Joseph; Edelman, Martin J.; Belani, Chandra P.; Socinski, Mark A.; Monberg, Matthew J.; Chen, Ruqin; Obasaju, Coleman K.

Book ID: 119320358
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 382 KB
Volume: 70
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2010.02.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Weekly nab-Paclitaxel in Combination Wit

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial

✍ Socinski, M. A.; Bondarenko, I.; Karaseva, N. A.; Makhson, A. M.; Vynnychenko, I 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 207 KB

O-082 A randomized phase III trial compa

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Vinorelbine plus gemcitabine followed by

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

✍ Kaoru Kubota; Masaaki Kawahara; Mitsumasa Ogawara; Yutaka Nishiwaki; Kiyoshi Kom 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 173 KB

Cost-effectiveness analysis of cisplatin

Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer

✍ Sumitra THONGPRASERT; Unchalee PERMSUWAN; Chidchanok RUENGORN; Chaiyut CHAROENTU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Paclitaxel/Carboplatin/Gemcitabine Versu

Paclitaxel/Carboplatin/Gemcitabine Versus Gemcitabine/Vinorelbine in Advanced Non–Small-Cell Lung Cancer: A Phase II/III Study of the Minnie Pearl Cancer Research Network

✍ F. Anthony Greco; David R. Spigel; Michel E. Kuzur; Dianna Shipley; James R. Gra 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB